Open AccessTreatment of Hidradenitis Suppurativa With Etanercept Injection
Author(s) -
David R. Adams,
Jessica A. Yankura,
Anneli C. Fogelberg,
Bryan Anderson
Publication year - 2010
Publication title -
archives of dermatology
Language(s) - English
Resource type - Journals
eISSN - 1538-3652
pISSN - 0003-987X
DOI - 10.1001/archdermatol.2010.72
Subject(s) - medicine , etanercept , dermatology life quality index , placebo , quality of life (healthcare) , randomized controlled trial , dermatology , hidradenitis suppurativa , physical therapy , surgery , psoriasis , pathology , tumor necrosis factor alpha , alternative medicine , nursing , disease
To observe the effects of etanercept treatment on the cutaneous manifestations of hidradenitis suppurative (HS) and to evaluate physician and patient global assessment scores of cutaneous manifestations.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom